ArticleFrontiers in medicine2026
Explainability-informed patient-disjoint evaluation of deep learning for plus disease in retinopathy of prematurity with an ophthalmologist reader study.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Plus disease is a treatment-relevant sign of retinopathy of prematurity, but fundus images from the same infant may differ in image quality, posterior-pole coverage, and visible vascular severity. We evaluated deep-learning classification using a patient-disjoint design, within-infant variability, and an ophthalmologist reader study. Methods: The primary analysis included 732 Phoenix ICON fundus images from 38 infants, assigned exclusively to a 634-image development pool or a 98-image hold-out set from eight previously unseen infants. Five pretrained convolutional neural networks were evaluated at the image level. Hold-out predictions were grouped by infant and laterality to characterize descriptive within-infant variation. A historical secondary analysis used a random image-level partition without enforced patient separation and was considered exploratory. Two ophthalmologists independently graded 30 unique isolated images for inter-observer analysis; 10 were presented twice, resulting in 40 presentations for intra-observer repeatability. Results: DenseNet121 achieved an image-level ROC-AUC of 0.929; however, infant-equal-weighted image-level ROC-AUC was 0.905 and leave-one-infant-out ROC-AUC ranged from 0.838 to 0.989, demonstrating sensitivity to the small clustered hold-out cohort. At a development-defined threshold of 0.0184, sensitivity increased to 98.0%, while specificity decreased to 46.8%. Within-infant probability variability was observed across all five CNN architectures. Ophthalmologists 1 and 2 assessed 14/18 and 17/18 plus-reference images, respectively, as Healthy. Exact three-category inter-observer agreement was 26/30 (86.7%), and both reproduced the same severity grade for all 10 repeated images. Conclusions: Patient-disjoint evaluation revealed substantial uncertainty in image-level performance and variability among images from the same infant. Cluster-aware analyses showed dependence on the small hold-out cohort, while the development-defined operating point demonstrated a marked sensitivity-specificity trade-off. The reader study showed that an examination-derived reference label and the diagnostic evidence visible in an isolated image are not equivalent, despite high inter-observer agreement and complete categorical repeatability. Because examination identifiers were unavailable, within-infant analyses were interpreted descriptively and not as infant or examination-level diagnostic performance. Clinically useful systems should assess image quality, select informative views, and integrate evidence across multiple images and both eyes. External prospective multicentre validation is required before clinical implementation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.